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Effect of microdermabrasion on skin histology in vivo: selective removal of stratum 
corneum for intra-epidermal vaccine delivery 
Objective: The objective of this study was to test the hypothesis that microdermabrasion 
can be used to selectively remove the stratum corneum layer to enable delivery of 
vaccines primarily to the epidermal layer of the skin. The overall expectation driving this 
study was that targeting the Langerhans cells residing in the epidermal layer of the skin 
for vaccine delivery will increase the robustness of the immune response. 
Methods: Microdermabrasion was performed in vivo on the skin of rhesus macaques and 
human volunteers using the mobile (back-and-forth movement on the skin) and the 
stationary mode of microdermabrasion. Biopsies were collected from microdermabraded 
skin and histologically characterized. Histological sections were stained with 
hematoxylin and eosin and visually examined using a microscope to assess the extent of 
damage of the stratum corneum and the epidermis. M V A (Modified Vaccinia Ankara) 
was topically applied on microdermabraded skin of rhesus macaques to test the ability of 
M V A to induce an immune response. In addition, sodium fluorescein was also topically 
applied on microdermabraded skin to assess the ability of hydrophilic and low molecular 
compounds to diffuse across microdermabraded skin. 
Results: Selective removal of stratum corneum was observed using the mobile mode of 
microdermabrasion. In rhesus macaques, increase in the number of passes (10, 30, 50 80 
and 100 passes) led to an increase in the degree of stratum corneum and epidermis 
removal (vacuum pressure = 50 kPa). At 50 passes, selective removal of stratum corneum 
was observed with little damage to the epidermis. Quantitative measurement 
demonstrated that at 50 passes, greater than or equal to 2 5 % of the skin had stratum 
corneum removed, and only less than 2 5 % of the skin had epidermal loss. Similar effects 
were observed for human volunteers using a vacuum pressure of 25 kPa. This suggests 
that with the mobi le mode of microdermabrasion complete removal of stratum corneum 
can be achieved with minimal damage to the epidermis. 
Using the stationary mode , selective stratum corneum removal was not observed. 
In rhesus macaques , microdermabrasion at 30 kPa and 50 kPa vacuum pressures each 
with a skin-contact t ime of 3 s and 6 s did not result in stratum corneum removal. 
However, blister (separation at the epidermal-dermal junction) formation was observed at 
the 50 kPa condition. Similar effects were observed for human subjects at a vacuum 
pressure of 30 kPa and 45 kPa, each with a skin-contact t ime of 3 s. In humans, the 
blisters were observed at both 30 kPa and 45 kPa conditions. 
Next, delivery of sodium fluorescein and M V A virus through microdermabraded 
skin was demonstrated. Fluorescent micrographs of histological sections of 
microdermabraded skin after application of sodium fluorescein showed high degree of 
fluorescence as compared to non-microdermabraded skin. Further, M V A specific 
antibodies were generated in monkeys following topical application of M V A on 
microdermabraded skin. Thus, in this study, we demonstrated for the first t ime that 
microdermabrasion can be used to selectively remove the stratum corneum layer and also 
demonstrated the ability to deliver model hydrophilic compounds and virus through the 
microdermabraded skin. 
Conclusions: Microdermabrasion can be used to selectively remove the stratum corneum 
layer to target the Langerhans cells of the epidermis for vaccine delivery or transdermal 
drug delivery. Antibodies were generated against M V A following topical application of 
M V A on microdermabraded skin, indicating the potential of microdermabrasion as a 
method of intra-epidermal vaccination. 
